Feng, Lifeng <br/><br/>
Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway.  [electronic resource] 

 -  Free radical research  Jan 2019 
 - 82-93 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1029-2470 
<br/><br/><label>Standard No.: </label>10.1080/10715762.2018.1554901  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Dose-Response Relationship, Drug<br/>Isoproterenol--antagonists & inhibitors<br/>Male<br/>Myocardial Infarction--chemically induced<br/>Myocytes, Cardiac--drug effects<br/>NG-Nitroarginine Methyl Ester--pharmacology<br/>Nitric Oxide--biosynthesis<br/>Nitric Oxide Synthase Type III--antagonists & inhibitors<br/>Phosphorylation--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Resveratrol--antagonists & inhibitors<br/>Signal Transduction--drug effects<br/>Structure-Activity Relationship<br/>Vascular Endothelial Growth Factor B--antagonists & inhibitors